Tech Company Financing Transactions
OxyPlus Funding Round
Index Ventures and private investors invested in a $2.6 million capital raise for OxyPlus. This venture round was announced on 12/31/2008.
Transaction Overview
Company Name
Announced On
12/31/2008
Transaction Type
Venture Equity
Amount
$2,643,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
300 Market St.
Boston, MA 02135
USA
Boston, MA 02135
USA
Phone
Email Address
Not Recorded
Overview
OxyPlus is a developer of small molecule compounds for the treatment of cardiovascular issues and cancer.
Management Team
Browse more venture capital transactions:
Prev: 12/31/2008: ViOptix venture capital transaction
Next: 12/31/2008: Logical Therapeutics venture capital transaction
Share this article
About Our VC Transactions Data
We report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs